Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02707887 · ClinicalTrials.gov registry record · NA
Technology Enhanced Behavioral Activation Treatment for Substance Use
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
NCT02707887: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT02707887 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02707887, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1. test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use 2. use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.
Primary Outcome
The Time Line Follow Back is a self-report measure of drug and alcohol use.
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL LETS ACT
- BEHAVIORAL LETS ACT-SE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-12 |
| Phase | NA |
What the finished NCT02707887 record still lists
NCT02707887 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.
NCT02707887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02707887 about?
NCT02707887 is a clinical study titled "Technology Enhanced Behavioral Activation Treatment for Substance Use". The purpose of this study is to: 1. test the effect of a smartphone enhanced LETS ACT (LETS ACT-SE) on frequency of substance use 2. use functional magnetic resonance imaging (fMRI) to test the relationship between neuromarkers of reward sensitivity on frequency of substance use.
What is the current status of trial NCT02707887?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2016-01. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02707887?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), LETS ACT (BEHAVIORAL), LETS ACT-SE (BEHAVIORAL).
Who is sponsoring clinical trial NCT02707887?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02707887's enrollment target sits among peer trials
206 499th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia